Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00725894 · ClinicalTrials.gov registry record
Pediatric Locking Nail for the Treatment of Femoral Fractures in Children
A clinical trial, sponsored by Zimmer Biomet.
- Completed
- Registry status
- 33
- Enrollment target
NCT00725894: Completed study, sponsored by Zimmer Biomet.
NCT00725894 is a clinical trial that has completed, run by Zimmer Biomet. The registered enrollment target is 33 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00725894 has completed, sponsored by Zimmer Biomet.
- COMPLETED
- Registry status
- 33 participants
- Enrollment target
Study Summary
The purpose of this multi-center prospective clinical outcomes study is to determine validity and safety of the pediatric locking nail for femoral fracture management in children with open physes.
Interventions
- DEVICE Pediatric Locking Nail
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2007-11 |
| Est. Completion | 2013-11 |
What the finished NCT00725894 record still lists
NCT00725894 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 33 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Pediatric Locking Nail is the first listed.
NCT00725894 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00725894 about?
NCT00725894 is a clinical study titled "Pediatric Locking Nail for the Treatment of Femoral Fractures in Children". The purpose of this multi-center prospective clinical outcomes study is to determine validity and safety of the pediatric locking nail for femoral fracture management in children with open physes.
What is the current status of trial NCT00725894?
This trial is currently completed. The enrollment target is 33 participants. The study started on 2007-11. Estimated completion is 2013-11.
What interventions are being tested in trial NCT00725894?
The interventions under investigation include: Pediatric Locking Nail (DEVICE).
Who is sponsoring clinical trial NCT00725894?
This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02861898 · 33 participants · Phase 1
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
- NCT04871607 · 33 participants · Phase 2
Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma
- NCT05071937 · 33 participants · Phase 2
ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer
- NCT05168618 · 33 participants · Phase 2
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia